CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation

The blockade of inhibitory receptors such as CTLA-4 (CD152) is being used as immune-checkpoint therapy, offering a powerful strategy to restore effective immune responses against tumors. To determine signal components that are induced under the control of CTLA-4 we analyzed activated murine CD8(+) T...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingel, Holger, Wissing, Josef, Arra, Aditya, Schanze, Denny, Lienenklaus, Stefan, Klawonn, Frank, Pierau, Mandy, Zenker, Martin, Jänsch, Lothar, Brunner-Weinzierl, Monika C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596418/
https://www.ncbi.nlm.nih.gov/pubmed/28644433
http://dx.doi.org/10.1038/cdd.2017.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596418/
https://www.ncbi.nlm.nih.gov/pubmed/28644433
http://dx.doi.org/10.1038/cdd.2017.102

Ejemplares similares